Explained: How do scientists make cell and gene therapy products?

The early steps of viral vector production influence cell and gene therapy success.

Since the 1990s, cell and gene therapy research has expanded to include an increasing number of FDA-approved therapies for conditions ranging from cancer to rare hereditary diseases. The versatility of cell and gene therapy lies in the ability to modify and introduce any gene sequence into cells. Manufacturing enough cell and gene therapy products and transferring those products safely across cell membranes relies on critical early steps in therapeutic development. 

Download this Explainer Article from Mirus to learn more about how scientists produce safe and effective products for cell and gene therapy.

Sponsored by